Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes

Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes

Abstract The approval of Syfovre® (pegcetacoplan) and Iverzay® (avacincaptad pegol) for the treatment of geographic atrophy (GA) marks a significant advancement in retinal disease therapy, offering both complement 3 and complement 5 inhibitors. With this breakthrough, an increase in intravitreal inj...

Full description

Bibliographic Details
Main Authors: Carsten H. Meyer, Gustavo Barreto Melo, Arshad M. Khanani
Format: Article
Language:English
Published: BMC 2023-12-01
Series:International Journal of Retina and Vitreous
Subjects:
Avacincaptad pegol
Glaucoma
Intraocular pressure
Pegcetacoplan
Retinal nerve fiber layer
Online Access:https://doi.org/10.1186/s40942-023-00517-1

Internet

https://doi.org/10.1186/s40942-023-00517-1

Similar Items